Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 20Mycosis Fungoides 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Lymphoma, Non-Hodgkin 16Lymphoma, Mantle-Cell 16Lymphoma, Large-Cell, Immunoblastic 16Lymphoma, Large B-Cell, Diffuse 16Lymphoma, Follicular 16Lymphoma, B-Cell, Marginal Zone 16Leukemia, Lymphocytic, Chronic, B-Cell 16Hodgkin Disease 16Burkitt Lymphoma 16Sezary Syndrome 15Leukemia, Myeloid, Acute 15Multiple Myeloma 14Lymphoma 14Leukemia, Myeloid, Accelerated Phase 14Congenital Abnormalities 14Leukemia, Myeloid, Chronic-Phase 13Myeloproliferative Disorders 12Primary Myelofibrosis 11Myelodysplastic Syndromes 11Leukemia, Myelomonocytic, Chronic 11Leukemia 11Blast Crisis 11Recurrence 10Neoplasms, Plasma Cell 10Waldenstrom Macroglobulinemia 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, Large-Cell, Anaplastic 9

Interventions

Peripheral Blood Stem Cell Transplantation 6fludarabine phosphate 5Whole-Body Irradiation 5Cyclosporine 5Mycophenolic Acid 4Cyclophosphamide 4Epoetin Alfa 3Darbepoetin alfa 3liposomal amphotericin B 2Therapeutics 2Morphine 2Methylprednisolone 2Filgrastim 2Fentanyl 2Etoposide 2Early Intervention, Educational 2Caspofungin 2Busulfan 2Antilymphocyte Serum 2pyroxamide 1nelarabine 1ferrous sulfate 1ferric gluconate 1ethanolamine oleate 1Watchful Waiting 1Valganciclovir 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Thiotepa 1Tetradecanoylphorbol Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Immunoglobulin Light-chain Amyloidosis × Methotrexate × Dermatologic × Clear all
NCT00245037 2017-09-27

Bu Flu TBI

OHSU Knight Cancer Institute

Phase 1/2 Completed
147 enrolled 19 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡